Endocannabinoid System Research: Cannabinoids for Children
Cannabinoids for pediatric care have been studied in various medical conditions with evolving evidence. The strongest data supports use in specific epilepsy syndromes. Safety and efficacy findings in other pediatric conditions remain limited and variable.
Cannabinoid Clinical Trials: Cannabis Use for Anxiety
Cannabis use for anxiety shows varied effects depending on product type and cannabinoid content. Clinical trials reveal that CBD may reduce anxiety, while THC effects vary. Understanding these differences helps guide safer cannabis use for anxiety…
Research on Cannabis Compounds and Metabolic Dysfunction in Adults
This article explores cannabis compounds metabolic dysfunction and their potential impact on reversing disease affecting one-third of adults. The research highlights emerging findings on cannabis compounds as a possible intervention for metabolic health.…
Medical Cannabis for Anxiety & Tourette: Clinical Evidence
Cannabinoid clinical trials anxiety tourette review highlight measurable reductions in anxiety symptoms and Tourette syndrome with specific cannabinoid formulations. Evidence varies by formulation and dose, emphasizing no one-size-fits-all approach.…
Cannabinoids in Pediatric Care: Evidence-Based Clinical Review
Cannabinoid use in children is an evolving area with limited rigorous evidence. Most data comes from observational studies rather than controlled trials. This review highlights the current clinical evidence and safety considerations for cannabinoids in…
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinically meaningful reduction in drop seizures has been observed in Lennox-Gastaut syndrome patients treated with cannabidiol. Clinical trials show that even reductions below 50% can improve patient quality of life. Caregiver-reported outcomes align…
Cannabidiol as a Therapeutic Alternative for PTSD: From Bench to Human Trials
Post-traumatic stress disorder (PTSD) affects many and current treatments often fall short. The endocannabinoid system emotional memory is key in PTSD’s pathology. Cannabidiol shows promise as a therapeutic alternative by modulating this system.